KIMBERLY BUNKER: Open Payments
NPI 1669991287 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 32 payments from 21 companies in 2025. Trend: 2023 $669 · 2024 $705 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $101 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $70 |
| Eisai Inc. | 3 | $59 |
| ABBVIE INC. | 3 | $52 |
| Exelixis Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| PFIZER INC. | 2 | $36 |
| ARRAY BIOPHARMA INC | 1 | $30 |
| Geron Corporation | 1 | $28 |
Products named: KEYTRUDA, KISQALI, ICLUSIG, Lenvima, CABOMETYX, LIBTAYO, EMRELIS, LORBRENA.
Industry payments across NC — which companies pay providers there.
